APO-21 receptor agonist and CPT-11 synergism

Details for Australian Patent Application No. 2009200101 (hide)

Owner Genentech, Inc.

Inventors Benyunes, Mark C.; Ashkenazi, Avi J.; Schwall, Ralph H.

Agent Griffith Hack

Pub. Number AU-A-2009200101

Parent 2005202006

Filing date 9 January 2009

Wipo publication date 5 February 2009

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

5 February 2009 Application Open to Public Inspection

  Published as AU-A-2009200101

5 February 2009 Complete Application Filed

6 August 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read APO-2L receptor agonist and CPT-11 synergism

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200102-Method and apparatus for inspecting inter-layer address binding protocols

2009200100-Utilization of starch products for biological production by fermentation